Participants 223 366 6
21 patients with coronary artery disease who were receiving placebo, acebutolol, and propranolol in a double-blind, randomized, crossover study
Participants 513 574 4
26 patients with chronic angina pectoris receiving acebutolol
Participants 981 1086 3
13 patients with stable angina pectoris, single-pass studies of left ventricular function with indium 113
Participants 1272 1341 3
patients with coronary disease and a wide range of ejection fractions
